Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNorth Atl.smlr Regulatory News (NAS)

Share Price Information for North Atl.smlr (NAS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3,900.00
Bid: 3,900.00
Ask: 3,910.00
Change: -20.00 (-0.51%)
Spread: 10.00 (0.256%)
Open: 3,930.00
High: 3,930.00
Low: 3,900.00
Prev. Close: 3,920.00
NAS Live PriceLast checked at -
North Atlantic Smaller Companies is an Investment Trust

To provide capital appreciation through investment in a portfolio of smaller companies principally based in countries bordering the North Atlantic Ocean.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Management Statement

17 Dec 2013 09:08

RNS Number : 7238V
North Atlantic Smlr Co Inv Tst PLC
17 December 2013
 



NORTH ATLANTIC SMALLER COMPANIES INVESTMENT TRUST PLC

 

INTERIM MANAGEMENT STATEMENT FOR THE PERIOD ENDED 31 OCTOBER 2013

 

To the members of North Atlantic Smaller Companies Investment Trust PLC

This interim management statement has been produced solely to provide additional information to shareholders as a body in accordance with the relevant requirements of the UK Listing Authority's Disclosure and Transparency Rules. It should not be relied upon by any other party or for any other purpose.

 

This interim management statement relates to the period from 1 August 2013 to 31 October 2013, and contains information that covers this period, and up to the date of publication of this interim management statement, unless otherwise specified.

 

Investment Objective

The objective of North Atlantic Smaller Companies Investment Trust PLC ("the Company") is to provide capital appreciation through investment in a portfolio of smaller companies principally based in countries bordering the North Atlantic Ocean.

 

Financial Highlights

Cumulative performance

As at

31 October 2013

3 months %

6 months %

1 year 

%

3 years %

5 years %

Diluted NAV*

1,864p 

2.2 

8.4 

25.7

36.7 

84.9 

Mid-market price

1,588p 

6.4 

13.8 

38.0

52.0 

146.2 

Discount to diluted NAV *

14.8% 

Standard & Poor's 500 Composite Index **

1,095.1 

(1.2)

6.5 

25.1

48.4 

81.7 

Russell 2000 **

685.9 

(0.2)

12.4 

35.1

56.4 

105.1 

FTSE All-Share Index

3,585.3 

2.2 

5.8 

18.6

22.1 

64.2 

US Dollar/Sterling exchange rate

1.6066 

(6.0)

(3.2)

0.3

(0.5)

0.6 

 

* Following the conversion of the Loan Notes the performance is shown on the diluted NAV, excluding retained revenue for the period, only. The Board considers that this accurately reflects the underlying performance of the Company

** Sterling adjusted.

 

 

Material Events and Transactions during the Period

 

During the period under review, the Company's holdings in Bionostics and Orthoproducts were sold at a good uplift to the year-end valuation and at a significant premium to cost. As a result, the Company now has cash or near cash balances of circa £80 million.

 

 

Transactions in Own Shares

 

On 26 September 2013, 1,450 Ordinary shares were bought back for cancellation, at a total cost to the Company of £22,000.

 

Since 31 October 2013, a further 13,483 Ordinary shares were bought back for cancellation, in two tranches, at the beginning of December 2013, at a total cost of £208,000.

 

Following these purchases the Company's issued share capital consists of 15,897,501 Ordinary shares.

 

 

 

TEN LARGEST INVESTMENTS AT 31 OCTOBER 2013

Gleeson (MJ) Group

UK Listed

11.5

US Treasury Bills

US Treasury Bills

18.8

Oryx International Growth Fund Limited *

UK Listed

11.5

Trident Private Equity Fund III LLP

UK Unquoted

8.3

Hampton Investment Properties Limited

UK Unquoted

5.2

Bioquell

UK Listed

4.7

Guinness Peat Group **

UK Listed

4.5

Celsis AG

US Unquoted

3.5

AssetCo PLC

UK Listed

2.8

Goals Soccer Centres

UK Listed

2.6

% of total portfolio

73.4

 

* incorporated in Guernsey

** incorporated in New Zealand

 

SECTOR ANALYSIS OF INVESTMENTS AT FAIR VALUE AS AT 31 OCTOBER 2013

 

United 

United 

Total 

States 

Kingdom 

Europe 

Investment Companies

20.5

20.5

Treasury Bills

18.8

18.8

Construction & Materials

11.5

11.5

Real Estate

0.2

7.6

0.4

8.2

Support Services

1.0

5.1

6.1

Industrial Engineering

5.1

5.1

Health Care, Equipment & Services

0.2

4.7

4.9

Financial Services

4.5

4.5

Travel & Leisure

3.5

3.5

Media

3.2

3.2

Banks

3.1

3.1

Escrows

1.7

0.4

2.1

Oil & Gas Producers

1.2

0.8

2.0

General Retailers

1.7

1.7

Technology Hardware & Equipment

1.5

1.5

Food Producers

1.3

1.3

Industrial Transportation

1.3

1.3

Business Services

0.7

0.7

 

The financial information for the period ended 31 October 2013 contained within this Interim Management Statement has not been audited.

 

 

By order of the Board

 

 

Bonita Guntrip

Company Secretary

17 December 2013

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSGMMMZLNDGFZG
Date   Source Headline
18th Feb 200910:36 amRNSHolding(s) in Company
13th Feb 20093:13 pmRNSHolding(s) in Company
21st Jan 200910:33 amRNSHolding(s) in Company
15th Jan 200912:53 pmRNSDirectorate Change
23rd Dec 20084:13 pmRNSDirector/PDMR Shareholding
23rd Dec 20084:10 pmRNSDirector/PDMR Shareholding
17th Dec 20084:53 pmRNSInterim Management Statement
15th Dec 20082:54 pmRNSDirector/PDMR Shareholding
9th Dec 20089:09 amRNSHolding(s) in Company
2nd Dec 200811:11 amRNSTransaction in Own Shares
19th Nov 20081:37 pmRNSDirectorate Change
4th Nov 200811:03 amRNSAppointment of Financial Adviser and Broker
29th Oct 200812:29 pmRNSHolding(s) in Company
28th Oct 200810:46 amRNSDirector/PDMR Shareholding
15th Oct 20089:46 amRNSDirector/PDMR Shareholding
8th Oct 20083:58 pmRNSDirector/PDMR Shareholding
7th Oct 200811:32 amRNSDirector/PDMR Shareholding
1st Oct 20082:58 pmRNSDirector/PDMR Shareholding
30th Sep 200812:49 pmRNSHalf-Yearly Report
23rd Sep 20089:14 amRNSDirector/PDMR Shareholding
22nd Sep 200812:38 pmRNSInterim Results
10th Sep 20082:04 pmRNSHolding(s) in Company
8th Sep 200811:21 amRNSHolding(s) in Company
7th Aug 20086:27 pmRNSREPLACEMENT -CANCELLATION OF
4th Aug 200811:59 amRNSDirector/PDMR Shareholding
1st Aug 20082:36 pmRNSDirector/PDMR Shareholding
31st Jul 200810:19 amRNSCancellation of CULS
21st Jul 20084:19 pmRNSTransaction in Own Shares
16th Jul 20089:48 amRNSDirector/PDMR Shareholding
7th Jul 200811:00 amRNSTotal Voting Rights
2nd Jul 20084:03 pmRNSAdditional Listing
1st Jul 20083:18 pmRNSDirector/PDMR Shareholding
30th Jun 20084:19 pmRNSHolding(s) in Company
30th Jun 200810:45 amRNSTransaction in Own Shares
26th Jun 20082:32 pmRNSAGM Statement
17th Jun 200812:21 pmRNSTransaction in Own Shares
12th Jun 20082:52 pmRNSInterim Management Statement
3rd Jun 200811:14 amRNSAnnual Information Update
22nd May 20084:15 pmRNSAnnual Report and Accounts
9th May 200810:24 amRNSDirector/PDMR Shareholding
1st May 200812:50 pmRNSHolding(s) in Company
21st Apr 20084:55 pmRNSTransaction in Own Shares
17th Apr 20087:00 amRNSFinal Results
15th Feb 20089:54 amRNSHolding(s) in Company
4th Feb 20082:28 pmRNSPortfolio Update
24th Jan 200810:21 amRNSDirector/PDMR Shareholding
20th Dec 200710:51 amRNSInterim Management Statement
2nd Nov 200712:41 pmRNSPortfolio Update
24th Oct 20073:51 pmRNSDirector/PDMR Shareholding
16th Oct 200712:50 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.